| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Holland Laboratory, Department of Immunology, American Red Cross, Rockville, MD 20855; and
Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, MD 20892
Based on the tolerogenic properties of IgG carriers and B cell Ag presentation, we developed a retrovirally mediated gene expression approach for treatment of autoimmune conditions. In this study, we show that the IgG-Ag retroviral constructs, expressing myelin basic protein (MBP) or glutamic acid decarboxylase in B cells, can be used for the treatment of murine models for multiple sclerosis and diabetes. Transduction of syngeneic B cells with MBP-IgG leads to the amelioration of ongoing experimental allergic encephalomyelitis induced by the transfer of primed cells from PLxSJL F1 mice with ongoing disease and could be effective even after symptoms appeared. This effect is specific and does not involve bystander suppression because treatment with MBP-IgG does not affect disease induced after immunization with proteolipid protein immunodominant peptide plus MBP. Interestingly, if donor B cells are derived from gld mice (Fas ligand-negative), then tolerance is not induced with a model Ag although there was no evidence for Fas ligand-mediated deletion of target T cells. In spontaneous diabetes in nonobese diabetic mice, we were able to stop the ongoing autoimmune process by treatment at 7–10 wk with glutamic acid decarboxylase-IgG retrovirally transduced B cells, or attenuate it with B cells transduced with an insulin B chain (B9–23) epitope IgG fusion protein. Furthermore, IgG fusion protein gene therapy can also protect primed recipients from Ag-induced anaphylactic shock, and thus does not cause immune deviation. These results demonstrate proof of principle for future efforts to develop this approach in a clinical setting.
This article has been cited by other articles:
|
|
 |
|
  F. Frommer, T. J. A. J. Heinen, F. T. Wunderlich, N. Yogev, T. Buch, A. Roers, E. Bettelli, W. Muller, S. M. Anderton, and A. Waisman Tolerance without Clonal Expansion: Self-Antigen-Expressing B Cells Program Self-Reactive T Cells for Future Deletion J. Immunol., October 15, 2008; 181(8): 5748 - 5759. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Dalai, S. Mirshahidi, A. Morrot, F. Zavala, and S. Sadegh-Nasseri Anergy in Memory CD4+ T Cells Is Induced by B Cells J. Immunol., September 1, 2008; 181(5): 3221 - 3231. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Su, G. Carey, M. Maric, and D. W. Scott B Cells Induce Tolerance by Presenting Endogenous Peptide-IgG on MHC Class II Molecules via an IFN-{gamma}-Inducible Lysosomal Thiol Reductase-Dependent Pathway J. Immunol., July 15, 2008; 181(2): 1153 - 1160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Werner-Klein, C. Dresch, P. Marconi, and T. Brocker Transcriptional Targeting of B Cells for Induction of Peripheral CD8 T Cell Tolerance J. Immunol., June 15, 2007; 178(12): 7738 - 7746. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Litzinger, Y. Su, T. C. Lei, N. Soukhareva, and D. W. Scott Mechanisms of Gene Therapy for Tolerance: B7 Signaling Is Required for Peptide-IgG Gene-Transferred Tolerance Induction J. Immunol., July 15, 2005; 175(2): 780 - 787. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-M. R. Saint-Remy and M. G. Jacquemin Tolerance induction: a job for B cells? Blood, June 15, 2005; 105(12): 4551 - 4551. [Full Text] [PDF]
|
|
|
|
|
|
T. C. Lei and D. W. Scott Induction of tolerance to factor VIII inhibitors by gene therapy with immunodominant A2 and C2 domains presented by B cells as Ig fusion proteins Blood, June 15, 2005; 105(12): 4865 - 4870. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Takacs, C. Du Roure, S. Nabarro, N. Dillon, J. H. McVey, Z. Webster, A. MacNeil, I. Bartok, C. Higgins, D. Gray, et al. The regulated long-term delivery of therapeutic proteins by using antigen-specific B lymphocytes PNAS, November 16, 2004; 101(46): 16298 - 16303. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-C. Chen, A. Rivera, J. P. Dougherty, and Y. Ron Complete protection from relapsing experimental autoimmune encephalomyelitis induced by syngeneic B cells expressing the autoantigen Blood, June 15, 2004; 103(12): 4616 - 4618. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V C Kyttaris, Y-T Juang, and G C Tsokos Gene therapy in systemic lupus erythematosus Lupus, May 1, 2004; 13(5): 353 - 358. [Abstract] [PDF]
|
|
|
|
 |
|
 M. El-Amine, J. A. Hinshaw, and D. W. Scott In vivo induction of tolerance by an Ig peptide is not affected by the deletion of FcR or a mutated IgG Fc fragment Int. Immunol., July 1, 2002; 14(7): 761 - 766. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
